Publications by authors named "Claudio Favre"

Claim this Profile
A
A phase I/II study of brentuximab vedotin + AVD in paediatric patients with advanced Hodgkin lymphoma.
Marco A Salvino, Flavio A V Luisi, Mara A Pianovski, Franca Fagioli, Sidnei Epelman, Claudio Favre

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of primary hemophagocytic lymphohistiocytosis: a report on 143 patients from the Italian Registry.
Francesco Pegoraro, Aurora Chinnici, Linda Beneforti, Michele Tanturli, Irene Trambusti, Claudio Favre

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP Trial.
Arcangelo Prete, Edoardo Lanino, Francesco Saglio, Alessandra Biffi, Elisabetta Calore, Claudio Favre

Transplant Cell Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare migration in Italian paediatric haematology-oncology centres belonging to AIEOP.
Roberto Rondelli, Tamara Belotti, Riccardo Masetti, Franco Locatelli, Maura Massimino, Claudio Favre

Ital J Pediatr· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inside the Biology of the β3-Adrenoceptor.
Amada Pasha, Annalisa Tondo, Claudio Favre, Maura Calvani

Biomolecules· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma.
Nicoletta Nastasi, Amada Pasha, Gennaro Bruno, Angela Subbiani, Laura Pietrovito, Claudio Favre

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approaching hemophagocytic lymphohistiocytosis.
Aurora Chinnici, Linda Beneforti, Francesco Pegoraro, Irene Trambusti, Annalisa Tondo, Claudio Favre

Front Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma.
Gennaro Bruno, Nicoletta Nastasi, Angela Subbiani, Alessia Boaretto, Sara Ciullini Mannurita, Claudio Favre

Cancer Gene Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted treatment of solid tumors in pediatric precision oncology.
Ilaria Bertacca, Francesco Pegoraro, Annalisa Tondo, Claudio Favre

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-body magnetic resonance imaging for staging Langerhans cell histiocytosis in children and young adults.
Anna Perrone, Karoly Lakatos, Francesco Pegoraro, Irene Trambusti, Ilaria Fotzi, Claudio Favre

Pediatr Blood Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidative Stress and Natural Antioxidants in Osteoporosis: Novel Preventive and Therapeutic Approaches.
Gemma Marcucci, Vladana Domazetovic, Chiara Nediani, Jessica Ruzzolini, Claudio Favre

Antioxidants (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardio-Oncology in Childhood: State of the Art.
Elena Bennati, Francesca Girolami, Gaia Spaziani, Giovanni Battista Calabri, Claudio Favre

Curr Oncol Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-label caplacizumab as add-on therapy in a 9-year-old boy with refractory aTTP.
Marinella Veltroni, Francesco Pegoraro, Barbara Scappini, Francesca Brugnolo, Elisa Allegro, Claudio Favre

Ann Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of β3-Adrenergic Receptor in Bone Marrow Transplant as Therapeutical Support in Cancer.
Nicoletta Nastasi, Gennaro Bruno, Claudio Favre, Maura Calvani

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2).
Emanuela Palmerini, Cristina Meazza, Angela Tamburini, Gianni Bisogno, Virginia Ferraresi, Claudio Favre

Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.
Marco Cerrano, Massimiliano Bonifacio, Matteo Olivi, Antonio Curti, Michele Malagola, Claudio Favre

Haematologica· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
Filippo Consonni, Eleonora Gambineri, Claudio Favre

Ann Hematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Clinical and Hematological Characteristics of ε Thalassemia in an Italian Patient.
Ilaria Fotzi, Francesco Pegoraro, Elena Chiocca, Tommaso Casini, Massimo Mogni, Claudio Favre

Front Pediatr· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study.
Ebe Schiavo, Beatrice Martini, Enrico Attardi, Filippo Consonni, Sara Ciullini Mannurita, Claudio Favre

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP).
Marco Zecca, Andrea Ferrari, Paola Quarello, Marco Rabusin, Adriana Balduzzi, Claudio Favre

Tumori· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β2-and β3-Adrenergic Receptors Contribute to Cancer-Evoked Pain in a Mouse Model of Osteosarcoma Modulation of Neural Macrophages.
Gennaro Bruno, Francesco De Logu, Daniel Souza Monteiro de Araujo, Angela Subbiani, Federica Lunardi, Claudio Favre

Front Pharmacol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-2 Signaling Axis Defects: How Many Faces?
Filippo Consonni, Claudio Favre, Eleonora Gambineri

Front Pediatr· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Planned hematopoietic stem cell transplantation in a 17-month-old patient with high-risk acute myeloid leukemia and persistent SARS-CoV-2 infection.
Daniela Cuzzubbo, Francesco Pegoraro, Stefano Frenos, Tommaso Casini, Luisa Galli, Claudio Favre

Transfusion· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation.
Francesco Pegoraro, Claudio Favre

Ann Hematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β3-Adrenoreceptors as ROS Balancer in Hematopoietic Stem Cell Transplantation.
Amada Pasha, Maura Calvani, Claudio Favre

Int J Mol Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis